NeueHealth (NYSE:NEUE) Trading Up 1.3% – Here’s Why

NeueHealth, Inc. (NYSE:NEUE) was up 1.3% during trading on Tuesday . The company traded as high as $6.65 and last traded at $6.58. Approximately 2,225 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 20,469 shares. The stock had previously closed at $6.49.

NeueHealth Stock Performance

The company has a market cap of $54.48 million, a price-to-earnings ratio of -0.13 and a beta of 0.54. The company’s fifty day moving average is $6.61 and its two-hundred day moving average is $6.22.

NeueHealth (NYSE:NEUE) last released its quarterly earnings data on Thursday, March 20th. The company reported ($7.41) EPS for the quarter, missing the consensus estimate of ($2.29) by ($5.12). NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. The business had revenue of $232.64 million during the quarter, compared to analysts’ expectations of $261.80 million. On average, sell-side analysts anticipate that NeueHealth, Inc. will post -9.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other NeueHealth news, CEO George Lawrence Mikan III sold 13,180 shares of the business’s stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total value of $91,337.40. Following the completion of the transaction, the chief executive officer now directly owns 297,790 shares of the company’s stock, valued at approximately $2,063,684.70. The trade was a 4.24 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jay Matushak sold 4,448 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the sale, the chief financial officer now directly owns 41,592 shares in the company, valued at $280,330.08. The trade was a 9.66 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 68,178 shares of company stock valued at $467,763. Company insiders own 64.30% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NeueHealth stock. Virtu Financial LLC bought a new stake in shares of NeueHealth, Inc. (NYSE:NEUE) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 10,232 shares of the company’s stock, valued at approximately $76,000. Virtu Financial LLC owned 0.12% of NeueHealth as of its most recent SEC filing. 63.88% of the stock is owned by institutional investors and hedge funds.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.